1. Home
  2. INSP vs WVE Comparison

INSP vs WVE Comparison

Compare INSP & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inspire Medical Systems Inc.

INSP

Inspire Medical Systems Inc.

HOLD

Current Price

$50.53

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$5.92

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INSP
WVE
Founded
2007
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
INSP
WVE
Price
$50.53
$5.92
Analyst Decision
Buy
Strong Buy
Analyst Count
16
16
Target Price
$94.00
$29.81
AVG Volume (30 Days)
1.1M
3.1M
Earning Date
05-04-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
179.43
N/A
EPS
N/A
N/A
Revenue
$82,050,000.00
$3,704,000.00
Revenue This Year
$8.02
N/A
Revenue Next Year
$8.11
$85.67
P/E Ratio
N/A
N/A
Revenue Growth
62.18
149.43
52 Week Low
$38.91
$5.02
52 Week High
$147.03
$21.73

Technical Indicators

Market Signals
Indicator
INSP
WVE
Relative Strength Index (RSI) 63.20 45.35
Support Level $48.30 $5.48
Resistance Level $58.45 $6.48
Average True Range (ATR) 2.28 0.32
MACD 0.58 0.03
Stochastic Oscillator 81.23 41.62

Price Performance

Historical Comparison
INSP
WVE

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: